Vimarsana
Biggest News Aggregation in the World

Page 25 - Patrick Wingrove News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patrick Wingrove. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patrick Wingrove Today - Breaking & Trending Today

Moderna, Pfizer say updated Covid-19 shots generate strong response vs newer variant - Vimarsana News

Moderna, Pfizer say updated Covid-19 shots generate strong response vs newer variant

Moderna and rival Pfizer on Wednesday said their updated Covid-19 vaccines generated strong responses in testing against the highly mutated BA.2.86 subvariant of the coronavirus that has raised fears of a resurgence of infections.

Novartis Sues US Government Over Medicare Drug Price Regulation - Vimarsana News

Novartis Sues US Government Over Medicare Drug Price Regulation

Swiss drugmaker Novartis said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure medicine Entresto.

US senators push drugmakers for details on low-cost insulin programs - Vimarsana News

US senators push drugmakers for details on low-cost insulin programs

Two U.S. senators are demanding that the nation's three largest insulin makers, Novo Nordisk, Eli Lilly, and Sanofi, provide details by Sept. 15 of their programs to help Americans get their insulin for $35 a month or less.

Source: ksl.com
Novartis sues US government over Medicare drug price regulation - Vimarsana News

Novartis sues US government over Medicare drug price regulation

Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure medicine Entresto. The lawsuit, filed in federal court in New Jersey, is the first since the Biden administration on Tuesday released its list of 10 prescription medicines that will be subject to price negotiations by the Medicare health program, which covers 66 million people. Other drugs selected were Bristol Myers Squibb and Pfizer’s blood thinner Eliquis, Merck's diabetes drug Januvia, and Eliqu...

Source: yahoo.com
Novartis sues US government over Medicare drug price regulation - Vimarsana News

Novartis sues US government over Medicare drug price regulation

By Patrick Wingrove (Reuters) - Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price ...